Trial Profile
Double-blind, Placebo-controlled Study on Men With Lower Urinary Tract Symptoms to Assess Changes in Pressure Flow Study and in Molecular Profile of Prostatic Tissue After 12 Weeks Treatment With Tadalafil.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Tadalafil (Primary)
- Indications Benign prostatic hyperplasia; Lower urinary tract symptoms
- Focus Therapeutic Use
- 27 Apr 2021 Status changed from active, no longer recruiting to completed.
- 24 Sep 2019 Planned End Date changed from 1 Jun 2019 to 1 Jun 2020.
- 24 Sep 2019 Status changed from recruiting to active, no longer recruiting.